Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Blueprint Medicines Corporation
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||
| Equity | 2024 Stock Incentive Plan Common Stock, $0.001 par value per share | 457(h) | 9,200,000 | $104.84(2) | $964,528,000 (2) | .0001476 | $142,364.34 | |||||||
| Total Offering Amounts | $964,528,000 | $142, 364.34 | ||||||||||||
| Total Fee Offsets | __ | |||||||||||||
| Net Fee Due | $142, 364.34 | |||||||||||||
| (1) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional shares of common stock that may from time to time be offered or issued under the above-named plans to prevent dilution resulting from stock splits, stock dividends, recapitalizations or similar transactions effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of Common Stock. Pursuant to Rule 416(c) under the Securities Act, this Registration Statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the employee benefit plans described herein. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based upon the average of the high and low prices of the Registrant’s Common Stock as reported on The Nasdaq Global Select Market on June 18, 2024. |
